Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2014
10/28/2014US8871944 Thiazole derivative and process for producing same
10/28/2014US8871930 Preparation method of alpha-imatinib mesylate
10/28/2014US8871796 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
10/28/2014US8871778 Substituted pyrimidine compounds and their use as SYK inhibitors
10/28/2014US8871777 Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
10/28/2014US8871770 Carboxamide compounds and methods for using the same
10/28/2014US8871769 Ureas and their use in the treatment of heart failure
10/28/2014US8871766 Heterocyclic compounds
10/28/2014US8871756 Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
10/28/2014US8871753 Macrocyclic compounds and their use as kinase inhibitors
10/23/2014US20140315963 Heterocyclic acetamide compound
10/23/2014US20140315933 Chemical compounds
10/23/2014US20140315919 Highly selective sigma receptor ligands
10/23/2014US20140315917 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
10/23/2014US20140315912 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
10/23/2014US20140315906 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
10/23/2014US20140315899 Sulfonamides as trpm8 modulators
10/23/2014US20140315886 Quinazolines as therapeutic compounds and related methods of use
10/23/2014US20140315884 Ampk-activating heterocyclic compounds and methods for using the same
10/23/2014US20140315882 Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof
10/23/2014US20140315881 Compounds and methods
10/23/2014US20140315792 Anti-viral compounds
10/23/2014US20140315721 Pesticidal compositions and processes related thereto
10/23/2014US20140314785 Compositions and methods for inhibition of the jak pathway
10/21/2014US8865912 Benzimidazole derivatives as PI3 kinase inhibitors
10/21/2014US8865904 Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
10/21/2014US8865753 Compounds as cannabinoid receptor ligands
10/21/2014US8865752 Cytochrome P450 inhibitors and uses thereof
10/21/2014US8865750 Small molecule inhibitors of RGS proteins
10/21/2014US8865744 (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865731 Inhibitor of analgesic tolerance
10/21/2014US8865723 Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
10/21/2014US8865718 Heterocyclic inhibitors of glutaminase
10/21/2014US8865717 Heterocyclic compounds
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865704 Wnt pathway antagonists
10/21/2014US8865700 Collagen stimulators and their use in the treatment of skin
10/21/2014US8865682 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
10/21/2014US8865623 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds
10/21/2014US8865130 Methods and compositions for diagnostic and therapeutic targeting of COX-2
10/16/2014US20140309427 Substituted Pyran Derivatives
10/16/2014US20140309249 Inhibitors of c-jun-n-terminal kinase (jnk)
10/16/2014US20140309246 Methods and use of bifunctional enzyme-building clamp-shaped molecules
10/16/2014US20140309238 Fluoralkylcarbonyl-oxadiazoles
10/16/2014US20140309237 Compounds that modulate intracellular calcium
10/16/2014US20140309231 Nitrogen-containing heterocyclic compounds
10/16/2014US20140309226 Piperidinyl-substituted cyclic ureas as gpr119 modulators
10/16/2014US20140309212 Bruton's tyrosine kinase inhibitors
10/16/2014US20140309210 Indazole compounds, compositions and methods of use thereof
10/16/2014US20140309209 Pyrazine Kinase Inhibitors
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/14/2014US8859768 Heteroaryls and uses thereof
10/14/2014US8859608 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
10/14/2014US8859607 Crystalline complexes of agriculturally active organic compounds
10/14/2014US8859596 Compounds as cannabinoid receptor ligands
10/14/2014US8859592 Insecticidal compounds
10/14/2014US8859580 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
10/14/2014US8859541 6-alkynylpyridines
10/14/2014US8859534 2-carboxamide-7-piperazinyl-benzofuran derivatives
10/09/2014WO2014165065A1 Substituted piperidine compounds and their use as orexin receptor modulators
10/09/2014WO2014164526A1 Oxamazin antibiotics
10/09/2014WO2014164286A1 Dual sglt1/sglt2 inhibitors
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014161516A1 Oxa- and thia-diazoles useful in the treatment of tuberculosis
10/09/2014US20140304842 Red-shifted luciferins and methods of using same
10/09/2014US20140303218 Nitrogen Mustard Derivatives
10/09/2014US20140303213 Compositions and Methods for the Treatment of Metabolic Disorders
10/09/2014US20140303207 Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
10/09/2014US20140303187 Compounds and methods for kinase modulation, and indications therefor
10/09/2014US20140303171 Hiv protease inhibitors
10/09/2014US20140303157 Metalloenzyme inhibitor compounds
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303152 Benzothiazinethione derivatives and preparation methods and uses thereof
10/09/2014US20140303143 Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
10/09/2014US20140303127 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
10/09/2014US20140302022 2-carboxamide clycloamino urea derivatives for use in treating vegf-dependent diseases
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2786994A1 Compositions and methods for controlling nematodes
10/08/2014EP2786993A1 Compositions and methods for controlling nematodes
10/08/2014EP2786992A1 Compositions and methods for controlling nematodes
10/08/2014EP2785714A1 Improved modulators of hec1 activity and methods therefor
10/08/2014EP2785711A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785707A1 Novel 2h-indazoles as ep2 receptor antagonists
10/08/2014EP2785705A1 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof
10/08/2014EP2785695A1 New bicyclic dihydroisoquinoline-1-one derivatives
10/08/2014EP2785693A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors
10/08/2014EP2785692A1 Substituted anilines as ccr(4) antagonists
10/07/2014USRE45183 Heteroaryl-ureas and their use as glucokinase activators
10/07/2014US8853415 Modulators of ATP-binding cassette transporters
10/07/2014US8853412 Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
10/07/2014US8853409 Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853395 Process for the preparation of lurasidone hydrochloride
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853246 Pesticidal compositions
10/07/2014US8853230 Inhibitors of JAK
10/07/2014US8853210 Methods and intermediates for preparing pharmaceutical agents
10/07/2014US8853202 Modulators of CXCR7
10/07/2014US8852759 Compound having acridan ring structure, and organic electroluminescent device
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 628